108 related articles for article (PubMed ID: 10782382)
1. Disoxaril-related 3-(diethylamino)-5-phenylisoxazoles.
Mazzei M; Dondero R; Ledda B; Demontis F; Vargiu L
Farmaco; 2000 Feb; 55(2):119-24. PubMed ID: 10782382
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antirhinovirus activity of 3-(diethylamino)-5-phenylisoxazole derivatives.
Mazzei M; Garzoglio R; Balbi A; Grandi T; De Montis A; Corrias S; La Colla P
Farmaco; 1996 May; 51(5):351-9. PubMed ID: 8767845
[TBL] [Abstract][Full Text] [Related]
3. Conformationally restricted analogues of disoxaril: a comparison of the activity against human rhinovirus types 14 and 1A.
Mallamo JP; Diana GD; Pevear DC; Dutko FJ; Chapman MS; Kim KH; Minor I; Oliveira M; Rossmann MG
J Med Chem; 1992 Dec; 35(25):4690-5. PubMed ID: 1335081
[TBL] [Abstract][Full Text] [Related]
4. Antirhinoviral activity of heterocyclic analogs of Win 54954.
Bailey TR; Diana GD; Kowalczyk PJ; Akullian V; Eissenstat MA; Cutcliffe D; Mallamo JP; Carabateas PM; Pevear DC
J Med Chem; 1992 Nov; 35(24):4628-33. PubMed ID: 1335079
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-activity studies of some disubstituted phenylisoxazoles against human picornavirus.
Diana GD; Cutcliffe D; Oglesby RC; Otto MJ; Mallamo JP; Akullian V; McKinlay MA
J Med Chem; 1989 Feb; 32(2):450-5. PubMed ID: 2913305
[TBL] [Abstract][Full Text] [Related]
6. Antipicornavirus activity of tetrazole analogues related to disoxaril.
Diana GD; Cutcliffe D; Volkots DL; Mallamo JP; Bailey TR; Vescio N; Oglesby RC; Nitz TJ; Wetzel J; Giranda V
J Med Chem; 1993 Oct; 36(22):3240-50. PubMed ID: 8230114
[TBL] [Abstract][Full Text] [Related]
7. CoMFA analysis of the interactions of antipicornavirus compounds in the binding pocket of human rhinovirus-14.
Diana GD; Kowalczyk P; Treasurywala AM; Oglesby RC; Pevear DC; Dutko FJ
J Med Chem; 1992 Mar; 35(6):1002-8. PubMed ID: 1313108
[TBL] [Abstract][Full Text] [Related]
8. Quantitative structure-activity relationship studies of [(biphenyloxy)propyl]isoxazole derivatives. Inhibitors of human rhinovirus 2 replication.
Kuz'min VE; Artemenko AG; Muratov EN; Volineckaya IL; Makarov VA; Riabova OB; Wutzler P; Schmidtke M
J Med Chem; 2007 Aug; 50(17):4205-13. PubMed ID: 17665898
[TBL] [Abstract][Full Text] [Related]
9. A model for compounds active against human rhinovirus-14 based on X-ray crystallography data.
Diana GD; Treasurywala AM; Bailey TR; Oglesby RC; Pevear DC; Dutko FJ
J Med Chem; 1990 May; 33(5):1306-11. PubMed ID: 2158559
[TBL] [Abstract][Full Text] [Related]
10. Oxadiazoles as ester bioisosteric replacements in compounds related to disoxaril. Antirhinovirus activity.
Diana GD; Volkots DL; Nitz TJ; Bailey TR; Long MA; Vescio N; Aldous S; Pevear DC; Dutko FJ
J Med Chem; 1994 Jul; 37(15):2421-36. PubMed ID: 8057290
[TBL] [Abstract][Full Text] [Related]
11. Enantiomeric effects of homologues of disoxaril on the inhibitory activity against human rhinovirus-14.
Diana GD; Otto MJ; Treasurywala AM; McKinlay MA; Oglesby RC; Maliski EG; Rossmann MG; Smith TJ
J Med Chem; 1988 Mar; 31(3):540-4. PubMed ID: 2831362
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity studies of 5-[[4-(4,5-dihydro-2-oxazolyl) phenoxy]alkyl]-3-methylisoxazoles: inhibitors of picornavirus uncoating.
Diana GD; Oglesby RC; Akullian V; Carabateas PM; Cutcliffe D; Mallamo JP; Otto MJ; McKinlay MA; Maliski EG; Michalec SJ
J Med Chem; 1987 Feb; 30(2):383-8. PubMed ID: 3027340
[TBL] [Abstract][Full Text] [Related]
13. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P1 lactam moieties as L-glutamine replacements.
Dragovich PS; Prins TJ; Zhou R; Webber SE; Marakovits JT; Fuhrman SA; Patick AK; Matthews DA; Lee CA; Ford CE; Burke BJ; Rejto PA; Hendrickson TF; Tuntland T; Brown EL; Meador JW; Ferre RA; Harr JE; Kosa MB; Worland ST
J Med Chem; 1999 Apr; 42(7):1213-24. PubMed ID: 10197965
[TBL] [Abstract][Full Text] [Related]
14. Novel [(biphenyloxy)propyl]isoxazole derivatives for inhibition of human rhinovirus 2 and coxsackievirus B3 replication.
Makarov VA; Riabova OB; Granik VG; Wutzler P; Schmidtke M
J Antimicrob Chemother; 2005 Apr; 55(4):483-8. PubMed ID: 15743897
[TBL] [Abstract][Full Text] [Related]
15. Novel 5-arylcarbamoyl-2-methylisoxazolidin-3-yl-3-phosphonates as nucleotide analogues.
Kokosza K; Balzarini J; Piotrowska DG
Nucleosides Nucleotides Nucleic Acids; 2014; 33(8):552-82. PubMed ID: 25009989
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of 5-isoxazol-5-yl-2'-deoxyuridines exhibiting antiviral activity against HSV and several RNA viruses.
Lee YS; Park SM; Kim BH
Bioorg Med Chem Lett; 2009 Feb; 19(4):1126-8. PubMed ID: 19147352
[TBL] [Abstract][Full Text] [Related]
17. Heterocyclic nucleoside analogues: design and synthesis of antiviral, modified nucleosides containing isoxazole heterocycles.
Lee YS; Kim BH
Bioorg Med Chem Lett; 2002 May; 12(10):1395-7. PubMed ID: 11992785
[TBL] [Abstract][Full Text] [Related]
18. Binding affinities of structurally related human rhinovirus capsid-binding compounds are related to their activities against human rhinovirus type 14.
Fox MP; McKinlay MA; Diana GD; Dutko FJ
Antimicrob Agents Chemother; 1991 Jun; 35(6):1040-7. PubMed ID: 1656851
[TBL] [Abstract][Full Text] [Related]
19. Isoxazoles with antipicornavirus activity.
Diana GD; McKinlay MA; Brisson CJ; Zalay ES; Miralles JV; Salvador UJ
J Med Chem; 1985 Jun; 28(6):748-52. PubMed ID: 2989517
[TBL] [Abstract][Full Text] [Related]
20. An evaluation of the antirhinoviral activity of acetylfuran replacements for 3-methylisoxazoles. Are 2-acetylfurans bioisosteres for 3-methylisoxazoles?
Bailey TR; Diana GD; Mallamo JP; Vescio N; Draper TL; Carabateas PM; Long MA; Giranda VL; Dutko FJ; Pevear DC
J Med Chem; 1994 Nov; 37(24):4177-84. PubMed ID: 7990117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
